Integrating Preexposure Prophylaxis for Human Immunodeficiency Virus Prevention Into Womenʼs Health Care in the United States

2016 ◽  
Vol 128 (1) ◽  
pp. 37-43 ◽  
Author(s):  
Dominika Seidman ◽  
Shannon Weber
Keyword(s):  
United States ◽  
Health Care ◽  
Human Immunodeficiency Virus ◽  
The United States ◽  
Human Immunodeficiency Virus Prevention ◽  
Preexposure Prophylaxis ◽  
Immunodeficiency Virus

scholarly journals Hidden in Plain Sight: Identifying Women Living in the United States Who Could Benefit From HIV Preexposure Prophylaxis

2019 ◽  
Vol 222 (9) ◽  
pp. 1428-1431 ◽  
Author(s):  
B O Ojikutu ◽  
K H Mayer
Keyword(s):  
United States ◽  
Human Immunodeficiency Virus ◽  
Effective Means ◽  
The United States ◽  
Preexposure Prophylaxis ◽  
Immunodeficiency Virus ◽  
Barriers To Use ◽  
Hiv Acquisition

Abstract HIV preexposure prophylaxis (PrEP) with oral tenofovir/emtricitabine is an effective means of decreasing human immunodeficiency virus (HIV) acquisition among women. However, few women are prescribed and are taking PrEP. This article offers perspectives on barriers to use and strategies to increase uptake among women.

247. Disparities in Human Immunodeficiency Virus (HIV) Education and Testing Between Rural and Urban Youth in the United States

2020 ◽  
Vol 66 (2) ◽  
pp. S125
Author(s):  
Ashley Morgan Ebersole ◽  
Samantha J. Boch ◽  
Andrea E. Bonny ◽  
Deena J. Chisolm ◽  
Elise Berlan
Keyword(s):  
United States ◽  
Human Immunodeficiency Virus ◽  
Urban Youth ◽  
The United States ◽  
Hiv Education ◽  
Rural And Urban ◽  
Immunodeficiency Virus
Sign in / Sign up

Export Citation Format

Share Document